Immune Checkpoint Inhibitors (ICIs) in NSCLC: Immune Related Adverse Events (irAEs) and Outcomes. A Canadian Single Institution Experience

被引：2

作者：

Virik, K. ^{[1
]}

Basulaiman, B. ^{[1
]}

Robinson, A. ^{[1
]}

Hopman, W. ^{[2
]}

机构：

[1] Queens Univ, Khsc, Dept Oncol, Kingston, ON, Canada

[2] Kingston Gen Hlth Res Inst, Wj Henderson Ctr Patient Oriented Res, Connell 4, Kingston, ON, Canada

来源：

关键词：

irAEs; immunotoxicity; Immunotherapy;

D O I：

10.1016/j.jtho.2018.08.1564

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P3.01-04

引用

页码：S868 / S868

页数：1